RSS-Feed abonnieren
DOI: 10.1055/s-2008-1038293
Depression beim idiopathischen Parkinson-Syndrom
Teil 1: Epidemiologie, Pathophysiologie, Klinik und DiagnostikDepression in Parkinson's DiseasePart 1: Epidemiology, Signs and Symptoms, Pathophysiology and DiagnosisPublikationsverlauf
Publikationsdatum:
14. November 2008 (online)

Zusammenfassung
Nicht-motorische Störungen des idiopathischen Parkinson-Syndroms (IPS) wie depressive Symptome finden in den letzten Jahren zunehmend Beachtung, da sie die Lebensqualität der Patienten maßgeblich beeinträchtigen und sich auch auf die motorische Behinderung negativ auswirken. In der Gruppe der neuropsychiatrischen Störungen sind die depressiven Symptome am häufigsten. Doch trotz Häufigkeit und zunehmender Bedeutung wird die Depression beim IPS häufig nicht erkannt. Diagnostische Probleme bereiten die Symptomüberlappung depressiver Symptome mit motorischen und kognitiven Symptomen des IPS. Zudem fehlt es an validierten und standardisierten Meßmethoden, was letztlich auch dazu geführt hat, dass bislang keine genauen Angaben zur Frequenz depressiver Symptome bei Parkinsonerkrankungen vorliegen. Entsprechend finden sich in der Literatur je nach verwendetem Diagnoseinstrumentarium und Studiendesign Angaben zur Prävalenz depressiver Symptome beim IPS, die von 7 – 72 % reichen, mit ca. 40 % in den meisten Querschnittsstudien. Während es zu Prävalenz und Psychopathologie depressiver Störungen einige Studien mit unselektierten Parkinson-Patienten gibt, ist nur wenig über deren Genese und Langzeitverlauf bekannt. Die vorliegende Arbeit fasst die zurzeit vorliegenden Erkenntnisse zu Bedeutung, Häufigkeit, Pathogenese und Diagnostik depressiver Symptome beim IPS zusammen und schlägt auf der Basis vorhandener Daten ein Prozedere zu Screening und Diagnostik vor.
Abstract
Non-motor symptoms, such as psychiatric symptoms and autonomic dysfunction, are common co-morbid conditions in Parkinson's disease (PD) and major contributors to poor quality of life and disability. Within the group of neuropsychiatric conditions, depressive symptoms are the most common condition. Despite their frequency and importance, depressive symptoms can be difficult to assess and diagnose and thus depression in PD is frequently unrealized. Diagnostic challenges include the overlap of depressive symptoms with motor and non-motor symptoms of PD, such as dementia and apathy. Furthermore, there are no definite standards to assess and diagnose depression in PD leading also to the lack of exact data on the epidemiology of this non-motor symptom in PD. Depending on the diagnostic test and the study design the prevalence of depression in PD is reported between 7 and 72 % of PD patients with approximately 40 % in most cross-sectional studies. In contrast, the pathogenesis and long-term course of depression in PD remain elusive. Current hypothesis, however, includes that depressive symptoms are part of the core condition of PD when regarded as an entity. The present review summarizes the current knowledge on epidemiology, pathogenesis and diagnosis of depression in PD and proposes on this data base a standard procedure for screening and diagnosis of depressive symptoms in PD.
Schlüsselwörter
Depression - Morbus Parkinson - Epidemiologie - Pathophysiologie - Diagnostik - Skalen
Key words
depression - Parkinson's disease - epidemiology - pathophysiology - diagnosis - scales
Literatur
- 1
Schrag A.
Quality of life and depression in Parkinson's disease.
Journal of the neurological sciences.
2006;
248
151-157
MissingFormLabel
- 2
Weintraub D, Moberg P J, Duda J E. et al .
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Journal of the American Geriatrics Society.
2004;
52
784-788
MissingFormLabel
- 3
Shulman L M, Taback R L, Rabinstein A A. et al .
Non-recognition of depression and other non-motor symptoms in Parkinson's disease.
Parkinsonism Relat Disord.
2002;
8
193-197
MissingFormLabel
- 4
Weintraub D, Moberg P J, Duda J E. et al .
Recognition and treatment of depression in Parkinson's disease.
Journal of geriatric psychiatry and neurology.
2003;
16
178-183
MissingFormLabel
- 5
Chaudhuri K R, Healy D G, Schapira A H.
Non-motor symptoms of Parkinson's disease: diagnosis and management.
Lancet neurology.
2006;
5
235-245
MissingFormLabel
- 6
Veazey C, Aki S O, Cook K F. et al .
Prevalence and treatment of depression in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences.
2005;
17
310-323
MissingFormLabel
- 7
Taylor A E, Saint-Cyr J A, Lang A E. et al .
Parkinson's disease and depression. A critical re-evaluation.
Brain.
1986;
109 ( Pt 2)
279-292
MissingFormLabel
- 8
Nilsson F M, Kessing L V, Sorensen T M. et al .
Major depressive disorder in Parkinson's disease: a register-based study.
Acta psychiatrica Scandinavica.
2002;
106
202-211
MissingFormLabel
- 9
Mayeux R, Stern Y, Rosen J. et al .
Depression, intellectual impairment, and Parkinson disease.
Neurology.
1981;
31
645-650
MissingFormLabel
- 10
Ehmann T S, Beninger R J, Gawel M J. et al .
Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects.
Journal of geriatric psychiatry and neurology.
1990;
3
3-9
MissingFormLabel
- 11
Slaughter J R, Slaughter K A, Nichols D. et al .
Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's
disease.
The Journal of neuropsychiatry and clinical neurosciences.
2001;
13
187-196
MissingFormLabel
- 12
McDonald W M, Richard I H, DeLong M R.
Prevalence, etiology, and treatment of depression in Parkinson's disease.
Biological psychiatry.
2003;
54
363-375
MissingFormLabel
- 13
Leentjens A F.
Depression in Parkinson's disease: conceptual issues and clinical challenges.
Journal of geriatric psychiatry and neurology.
2004;
17
120-126
MissingFormLabel
- 14
Hughes A J, Daniel S E, Blankson S. et al .
A clinicopathologic study of 100 cases of Parkinson's disease.
Arch Neurol.
1993;
50
140-148
MissingFormLabel
- 15
Hughes A J, Daniel S E, Kilford L. et al .
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological
study of 100 cases.
J Neurol Neurosurg Psychiatry.
1992;
55
181-184
MissingFormLabel
- 16
Yesavage J A, Brink T L, Rose T L. et al .
Development and validation of a geriatric depression screening scale: a preliminary
report.
Journal of psychiatric research.
1982;
17
37-49
MissingFormLabel
- 17
Ravina B, Camicioli R, Como P G. et al .
The impact of depressive symptoms in early Parkinson disease.
Neurology.
2007;
69
342-347
MissingFormLabel
- 18 Barone P, Groot A A, Goetz C G. et al .Depression and antidepression use in Parkinson's disease: results from the PRODEST-PD
study. Brussels: 11th Congress of the European Federation of Neurological Societies (EFNS) 25 – 28 Aug 2007
MissingFormLabel
- 19
Pedersen K F, Larsen J P, Alves G. et al .
Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based
study.
Parkinsonism Relat Disord.
2008;
MissingFormLabel
- 20
Dujardin K, Sockeel P, Devos D. et al .
Characteristics of apathy in Parkinson's disease.
Mov Disord.
2007;
22
778-784
MissingFormLabel
- 21
Aarsland D, Larsen J P, Lim N G. et al .
Range of neuropsychiatric disturbances in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry.
1999;
67
492-496
MissingFormLabel
- 22
Starkstein S E, Mayberg H S, Preziosi T J. et al .
Reliability, validity, and clinical correlates of apathy in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences.
1992;
4
134-139
MissingFormLabel
- 23
Schrag A, Jahanshahi M, Quinn N.
What contributes to quality of life in patients with Parkinson's disease?.
Journal of neurology, neurosurgery, and psychiatry.
2000;
69
308-312
MissingFormLabel
- 24
Kuopio A M, Marttila R J, Helenius H. et al .
The quality of life in Parkinson's disease.
Mov Disord.
2000;
15
216-223
MissingFormLabel
- 25
Kuhn W, Heye N, Muller T. et al .
The motor performance test series in Parkinson's disease is influenced by depression.
J Neural Transm.
1996;
103
349-354
MissingFormLabel
- 26
Brown R, Jahanshahi M.
Depression in Parkinson's disease: a psychosocial viewpoint.
Advances in neurology.
1995;
65
61-84
MissingFormLabel
- 27
Cummings J L, Masterman D L.
Depression in patients with Parkinson's disease.
International journal of geriatric psychiatry.
1999;
14
711-718
MissingFormLabel
- 28
Santamaria J, Tolosa E, Valles A.
Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism.
Neurology.
1986;
36
1130-1133
MissingFormLabel
- 29
Shiba M, Bower J H, Maraganore D M. et al .
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control
study.
Mov Disord.
2000;
15
669-677
MissingFormLabel
- 30
Brown R G, MacCarthy B, Gotham A M. et al .
Depression and disability in Parkinson's disease: a follow-up of 132 cases.
Psychological medicine.
1988;
18
49-55
MissingFormLabel
- 31
Lemke M R, Fuchs G, Gemende I. et al .
Depression and Parkinson's disease.
J Neurol.
2004;
251 Suppl 6
VI/24-27
MissingFormLabel
- 32
Marder K, Tang M X, Cote L. et al .
The frequency and associated risk factors for dementia in patients with Parkinson's
disease.
Archives of neurology.
1995;
52
695-701
MissingFormLabel
- 33
Starkstein S E, Petracca G, Chemerinski E. et al .
Depression in classic versus akinetic-rigid Parkinson's disease.
Mov Disord.
1998;
13
29-33
MissingFormLabel
- 34
Giladi N, Treves T A, Paleacu D. et al .
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
J Neural Transm.
2000;
107
59-71
MissingFormLabel
- 35 Derix M MA, Gilhuis H J, Hoogendijk W J. Depressive syndrome in Parkinson' disease: diagnostic pitfalls. In: Wolters EC, Scheltens P (eds). Mental dysfunction in Parkinson's disease. Amsterdam: Krijek University Press 1993: 335-353
MissingFormLabel
- 36
Cummings J L.
Depression and Parkinson's disease: a review.
The American journal of psychiatry.
1992;
149
443-454
MissingFormLabel
- 37
Poewe W, Luginger E.
Depression in Parkinson's disease: impediments to recognition and treatment options.
Neurology.
1999;
52
S2-6
MissingFormLabel
- 38
Judd L L, Rapaport M H, Paulus M P. et al .
Subsyndromal symptomatic depression: a new mood disorder?.
The Journal of clinical psychiatry.
1994;
55 Suppl
18-28
MissingFormLabel
- 39
Maricle R A, Nutt J G, Carter J H.
Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion:
preliminary findings.
Mov Disord.
1995;
10
329-332
MissingFormLabel
- 40
Richard I H, Justus A W, Kurlan R.
Relationship between mood and motor fluctuations in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences.
2001;
13
35-41
MissingFormLabel
- 41
Marsh L, McDonald W M, Cummings J. et al .
Provisional diagnostic criteria for depression in Parkinson's disease: report of an
NINDS/NIMH Work Group.
Mov Disord.
2006;
21
148-158
MissingFormLabel
- 42
Dujardin K, Sockeel P, Delliaux M. et al .
The Lille Apathy Rating Scale: validation of a caregiver-based version.
Mov Disord.
2008;
23
845-849
MissingFormLabel
- 43
Lauterbach E C, Freeman A, Vogel R L.
Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's
disease.
The Journal of neuropsychiatry and clinical neurosciences.
2004;
16
29-36
MissingFormLabel
- 44
Nilsson F M, Kessing L V, Bolwig T G.
Increased risk of developing Parkinson's disease for patients with major affective
disorder: a register study.
Acta psychiatrica Scandinavica.
2001;
104
380-386
MissingFormLabel
- 45
Schuurman A G, Akker M van den, Ensinck K T. et al .
Increased risk of Parkinson's disease after depression: a retrospective cohort study.
Neurology.
2002;
58
1501-1504
MissingFormLabel
- 46
Angst J, Preisig M.
Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results
of a prospective study from 1959 to 1985.
Schweiz Arch Neurol Psychiatr.
1995;
146
5-16
MissingFormLabel
- 47
Angst J, Preisig M.
Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results
of a prospective study from 1959 to 1985.
Schweiz Arch Neurol Psychiatr.
1995;
146
17-23
MissingFormLabel
- 48
Remy P, Doder M, Lees A. et al .
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation
in the limbic system.
Brain.
2005;
128
1314-1322
MissingFormLabel
- 49
Mann J J.
Role of the serotonergic system in the pathogenesis of major depression and suicidal
behavior.
Neuropsychopharmacology.
1999;
21
99S-105S
MissingFormLabel
- 50
Sargent P A, Kjaer K H, Bench C J. et al .
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100 635:
effects of depression and antidepressant treatment.
Archives of general psychiatry.
2000;
57
174-180
MissingFormLabel
- 51
Meyer J H, Kapur S, Eisfeld B. et al .
The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone
PET imaging study.
The American journal of psychiatry.
2001;
158
78-85
MissingFormLabel
- 52
Meyer J H, Kapur S, Houle S. et al .
Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study.
The American journal of psychiatry.
1999;
156
1029-1034
MissingFormLabel
- 53
Messa C, Colombo C, Moresco R M. et al .
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder
depressed patients compared to healthy controls: a PET study.
Psychopharmacology.
2003;
167
72-78
MissingFormLabel
- 54
Zanardi R, Artigas F, Moresco R. et al .
Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed
patients responding to paroxetine treatment: a positron emission tomography scan study.
Journal of clinical psychopharmacology.
2001;
21
53-58
MissingFormLabel
- 55
Meyer J H.
Imaging the serotonin transporter during major depressive disorder and antidepressant
treatment.
J Psychiatry Neurosci.
2007;
32
86-102
MissingFormLabel
- 56
Meyer J H, Houle S, Sagrati S. et al .
Brain serotonin transporter binding potential measured with carbon 11-labeled DASB
positron emission tomography: effects of major depressive episodes and severity of
dysfunctional attitudes.
Archives of general psychiatry.
2004;
61
1271-1279
MissingFormLabel
- 57
Mann J J, Huang Y Y, Underwood M D. et al .
A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical
binding in major depression and suicide.
Archives of general psychiatry.
2000;
57
729-738
MissingFormLabel
- 58
Mann J J, Malone K M.
Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients.
Biological psychiatry.
1997;
41
162-171
MissingFormLabel
- 59
Brooks D J, Piccini P.
Imaging in Parkinson's disease: the role of monoamines in behavior.
Biological psychiatry.
2006;
59
908-918
MissingFormLabel
- 60
Kim S E, Choi J Y, Choe Y S. et al .
Serotonin transporters in the midbrain of Parkinson's disease patients: a study with
123I-beta-CIT SPECT.
J Nucl Med.
2003;
44
870-876
MissingFormLabel
- 61
O'Suilleabhain P E, Sung V, Hernandez C. et al .
Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective,
and cognitive associations.
Archives of neurology.
2004;
61
865-868
MissingFormLabel
- 62
Hoogendijk W J, Sommer I E, Tissingh G. et al .
Depression in Parkinson's disease. The impact of symptom overlap on prevalence.
Psychosomatics.
1998;
39
416-421
MissingFormLabel
- 63
Koenig H G, George L K, Peterson B L. et al .
Depression in medically ill hospitalized older adults: prevalence, characteristics,
and course of symptoms according to six diagnostic schemes.
The American journal of psychiatry.
1997;
154
1376-1383
MissingFormLabel
- 64 McDowell I, Newel C. Measuring health. A guide to rating scales and questionaires. 2nd ed. Oxford: Oxford University Press 1996
MissingFormLabel
- 65
Snaith R P, Zigmond A S.
The hospital anxiety and depression scale.
British medical journal Clinical research ed.
1986;
292
344
MissingFormLabel
- 66
Mondolo F, Jahanshahi M, Grana A. et al .
The validity of the hospital anxiety and depression scale and the geriatric depression
scale in Parkinson's disease.
Behavioural neurology.
2006;
17
109-115
MissingFormLabel
- 67
Hamilton M.
Development of a rating scale for primary depressive illness.
The British journal of social and clinical psychology.
1967;
6
278-296
MissingFormLabel
- 68
Dissanayaka N N, Sellbach A, Matheson S. et al .
Validity of Hamilton Depression Inventory in Parkinson's disease.
Mov Disord.
2007;
22
399-403
MissingFormLabel
- 69
Montgomery S A, Asberg M.
A new depression scale designed to be sensitive to change.
Br J Psychiatry.
1979;
134
382-389
MissingFormLabel
- 70 Fahn S, Elton R L, Committee U D. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB (eds). Recent developments in Parkinson's disease. Florham Park: Macmillan Healthcare Information 1987: 153-163, 293 – 304
MissingFormLabel
- 71
Schrag A, Barone P, Brown R G. et al .
Depression rating scales in Parkinson's disease: critique and recommendations.
Mov Disord.
2007;
22
1077-1092
MissingFormLabel
- 72
Kuhner C, Burger C, Keller F. et al .
Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results
from German samples.
Der Nervenarzt.
2007;
78
651-656
MissingFormLabel
- 73
Sockeel P, Dujardin K, Devos D. et al .
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying
apathy: validation in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry.
2006;
77
579-584
MissingFormLabel
- 74
Robert P H, Clairet S, Benoit M. et al .
The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's
disease and mild cognitive impairment.
International journal of geriatric psychiatry.
2002;
17
1099-1105
MissingFormLabel
- 75
Marin R S, Biedrzycki R C, Firinciogullari S.
Reliability and validity of the Apathy Evaluation Scale.
Psychiatry research.
1991;
38
143-162
MissingFormLabel
- 76
Pedersen K F, Larsen J P, Aarsland D.
Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a
screening and diagnostic instrument for apathy in patients with Parkinson's disease.
Parkinsonism Relat Disord.
2008;
14
183-186
MissingFormLabel
- 77
Primack B A.
The WHO-5 Wellbeing Index performed the best in screening for depression in primary
care.
ACP journal club.
2003;
139
48
MissingFormLabel
- 78
Mergl R, Seidscheck I, Allgaier A K. et al .
Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.
Depression and anxiety.
2007;
24
185-195
MissingFormLabel
- 79
Brand S, Dodel R, Hautzinger M. et al .
[Depression in Parkinson's disease. Assessment and treatment].
Der Nervenarzt.
2007;
78
715-727; quiz 728
MissingFormLabel
Prof. Dr. med. Alexander Storch
Klinik und Poliklinik für Neurologie, Technische Universität
Fetscherstraße 74
01307 Dresden
eMail: alexander.storch@neuro.med.tu-dresden.de